328 related articles for article (PubMed ID: 30772915)
1. Omega-3 fatty acid-derived mediators that control inflammation and tissue homeostasis.
Ishihara T; Yoshida M; Arita M
Int Immunol; 2019 Aug; 31(9):559-567. PubMed ID: 30772915
[TBL] [Abstract][Full Text] [Related]
2. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
[TBL] [Abstract][Full Text] [Related]
3. [Anti-inflammatory pro-resolving derivatives of omega-3 and omega-6 polyunsaturated fatty acids].
Nowak JZ
Postepy Hig Med Dosw (Online); 2010 Mar; 64():115-32. PubMed ID: 20354260
[TBL] [Abstract][Full Text] [Related]
4. Lipidomics of oxidized polyunsaturated fatty acids.
Massey KA; Nicolaou A
Free Radic Biol Med; 2013 Jun; 59(100):45-55. PubMed ID: 22940496
[TBL] [Abstract][Full Text] [Related]
5. Activation of Lipid Mediator Formation Due to Lipoprotein Apheresis.
Weylandt KH; Schmöcker C; Ostermann AI; Kutzner L; Willenberg I; Kiesler S; Steinhagen-Thiessen E; Schebb NH; Kassner U
Nutrients; 2019 Feb; 11(2):. PubMed ID: 30744123
[TBL] [Abstract][Full Text] [Related]
6. Omega-3 PUFA derived anti-inflammatory lipid mediator resolvin E1.
Seki H; Tani Y; Arita M
Prostaglandins Other Lipid Mediat; 2009 Sep; 89(3-4):126-30. PubMed ID: 19737659
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of omega-3 fatty acid-derived epoxyeicosanoids in cardiovascular and inflammatory diseases.
Schunck WH; Konkel A; Fischer R; Weylandt KH
Pharmacol Ther; 2018 Mar; 183():177-204. PubMed ID: 29080699
[TBL] [Abstract][Full Text] [Related]
8. Emerging roles of metabolites of ω3 and ω6 essential fatty acids in the control of intestinal inflammation.
Nagatake T; Kunisawa J
Int Immunol; 2019 Aug; 31(9):569-577. PubMed ID: 30722032
[TBL] [Abstract][Full Text] [Related]
9. n-3 fatty acid-derived lipid mediators in the brain: new weapons against oxidative stress and inflammation.
Farooqui AA
Curr Med Chem; 2012; 19(4):532-43. PubMed ID: 22204329
[TBL] [Abstract][Full Text] [Related]
10. Divergent shifts in lipid mediator profile following supplementation with n-3 docosapentaenoic acid and eicosapentaenoic acid.
Markworth JF; Kaur G; Miller EG; Larsen AE; Sinclair AJ; Maddipati KR; Cameron-Smith D
FASEB J; 2016 Nov; 30(11):3714-3725. PubMed ID: 27461565
[TBL] [Abstract][Full Text] [Related]
11. ω-3 Polyunsaturated fatty acids and their cytochrome P450-derived metabolites suppress colorectal tumor development in mice.
Wang W; Yang J; Nimiya Y; Lee KSS; Sanidad K; Qi W; Sukamtoh E; Park Y; Liu Z; Zhang G
J Nutr Biochem; 2017 Oct; 48():29-35. PubMed ID: 28672272
[TBL] [Abstract][Full Text] [Related]
12. Regulation of inflammation in cancer by eicosanoids.
Greene ER; Huang S; Serhan CN; Panigrahy D
Prostaglandins Other Lipid Mediat; 2011 Nov; 96(1-4):27-36. PubMed ID: 21864702
[TBL] [Abstract][Full Text] [Related]
13. Whatever happened to the epoxyeicosatrienoic Acid-like endothelium-derived hyperpolarizing factor? The identification of novel classes of lipid mediators and their role in vascular homeostasis.
Frömel T; Fleming I
Antioxid Redox Signal; 2015 May; 22(14):1273-92. PubMed ID: 25330284
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel omega-3 fatty acid-derived bioactive metabolites based on a targeted lipidomics approach.
Isobe Y; Arita M
J Clin Biochem Nutr; 2014 Sep; 55(2):79-84. PubMed ID: 25320453
[TBL] [Abstract][Full Text] [Related]
15. ω-3 polyunsaturated fatty acids-derived lipid metabolites on angiogenesis, inflammation and cancer.
Wang W; Zhu J; Lyu F; Panigrahy D; Ferrara KW; Hammock B; Zhang G
Prostaglandins Other Lipid Mediat; 2014 Oct; 113-115():13-20. PubMed ID: 25019221
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Pancreatic Carcinoma Growth Through Enhancing ω-3 Epoxy Polyunsaturated Fatty Acid Profile by Inhibition of Soluble Epoxide Hydrolase.
Xia R; Sun L; Liao J; Li H; You X; Xu D; Yang J; Hwang SH; Jones RD; Hammock B; Yang GY
Anticancer Res; 2019 Jul; 39(7):3651-3660. PubMed ID: 31262891
[TBL] [Abstract][Full Text] [Related]
17. Insight into the contribution of isoprostanoids to the health effects of omega 3 PUFAs.
Joumard-Cubizolles L; Lee JC; Vigor C; Leung HH; Bertrand-Michel J; Galano JM; Mazur A; Durand T; Gladine C
Prostaglandins Other Lipid Mediat; 2017 Nov; 133():111-122. PubMed ID: 28610769
[TBL] [Abstract][Full Text] [Related]
18. Cardioprotective mechanism of omega-3 polyunsaturated fatty acids.
Endo J; Arita M
J Cardiol; 2016 Jan; 67(1):22-7. PubMed ID: 26359712
[TBL] [Abstract][Full Text] [Related]
19. Lipidomic methodologies for biomarkers of chronic inflammation in nutritional research: ω-3 and ω-6 lipid mediators.
Dasilva G; Medina I
Free Radic Biol Med; 2019 Nov; 144():90-109. PubMed ID: 30902758
[TBL] [Abstract][Full Text] [Related]
20. [Fatty acid epoxides in the regulation of the inflammation].
Kytikova OY; Denisenko YK; Novgorodtseva TP; Bocharova NV; Kovalenko IS
Biomed Khim; 2022 Jun; 68(3):177-189. PubMed ID: 35717582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
